AdaptHealth (AHCO) Non-Current Deffered Revenue (2018 - 2019)
AdaptHealth's (AHCO) quarterly Non-Current Deffered Revenue came in at $7.9 million in Q3 2019, little changed year-on-year from $7.9 million in Q3 2018, and little changed quarter-over-quarter from $7.9 million in Q2 2019.
AdaptHealth (AHCO) Non-Current Deffered Revenue (2018 - 2019) Analysis & Trends
AdaptHealth's Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $7.9 million for Q3 2019.
- On a quarterly basis, Non-Current Deffered Revenue changed 0.0% year-over-year to $7.9 million in Q3 2019; TTM through Sep 2019 was $7.9 million, a 0.0% change from a year earlier, with the FY2018 full-year figure at $7.9 million, changed N/A from the prior year.
- Non-Current Deffered Revenue held at $7.9 million in Q3 2019 per AHCO's latest filing, from $7.9 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $7.9 million in Q1 2018 and bottomed at $7.9 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AdaptHealth | 1.42 Bn | 1.38 Bn | 111.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 7.88 Mn |
| Jun 30, 2019 | 7.88 Mn |
| Mar 31, 2019 | 7.88 Mn |
| Dec 31, 2018 | 7.88 Mn |
| Sep 30, 2018 | 7.88 Mn |
| Jun 30, 2018 | 7.88 Mn |
| Mar 31, 2018 | 7.88 Mn |